badge icon

This article was automatically translated from the original Turkish version.

Article

CRISPR-Cas System

Biology

+1 More

Quote

The CRISPR-Cas system is an immune mechanism used by bacteria and archaea to defend against viruses. In recent years, it has become a transformative tool in the field of gene editing revolution.


CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) are sequences found in the genomes of microorganisms. These sequences contain genetic material derived from viruses (bacteriophages) previously encountered by the bacteria. CRISPR sequences work with Cas (CRISPR-associated) proteins to recognize and cut foreign genetic material.


System operates in three main stages:

  1. Acquisition (Adaptation): When a bacterium is infected by a virus, it incorporates a fragment of the virus’s genetic material into its own CRISPR sequence.
  2. Expression (CRISPR RNA Production): RNA molecules (crRNA) are produced from the CRISPR sequences and combine with Cas proteins.
  3. Targeting and Cleavage: Cas proteins use the crRNA as a guide to locate and cut the target viral DNA, thereby preventing infection.

Use in Genetic Editing

The CRISPR-Cas9 system has been adapted by humans for gene editing purposes. The Cas9 protein is directed by a guide RNA to cut a specific region of DNA. Cell, when repairing this cut, allows researchers to introduce targeted genetic modifications. This method is used in many fields including the treatment of genetic disorders agricultural biotechnology and basic genetic research like.

Advantages and Ethical Debates

The CRISPR-Cas system has advantages such as high precision low cost and ease of application. However ethical concerns regarding unintended genetic changes off-target effects and its use in human embryos remain discussion.

This system has revolutionized genetic engineering and will play an increasingly important role in medicine agriculture and biotechnology in the future important.

Bibliographies

Erdemli Köse, Selinay Başak, Ünzile Sur, Anıl Yirün, Aylin Balcı, Belma Koçer Gümüşel, and Pınar Erkekoğlu. "CRISPR-Cas9 Teknolojisi, Güvenliliği ve Etik Açıdan Değerlendirilmesi." *J Lit Pharm Sci* 9, no. 1 (2020): 50-64. https://doi.org/10.5336/pharmsci.2019-70581.

Kılıç Tosun, Öznur, and Zübeyde Kesmen. "CRISPR-Cas Uygulamaları, Potansiyel Riskler ve Yasal Düzenlemeler." *Helal ve Etik Araştırmalar Dergisi* 4, no. 2 (2022): 11-42. https://doi.org/10.51973/head.1209563.

Author Information

Avatar
Authorİrem YüceDecember 23, 2025 at 10:49 AM

Tags

Discussions

No Discussion Added Yet

Start discussion for "CRISPR-Cas System" article

View Discussions

Contents

  • Use in Genetic Editing

  • Advantages and Ethical Debates

Ask to Küre